Clinical Overview > Condition/ Syndrome

You are looking at 1 - 1 of 1 items for :

  • Thyroid nodule x
  • Thyroid carcinoma x
Clear All
Alex González Bóssolo Endocrinology, Diabetes and Metabolism

Search for other papers by Alex González Bóssolo in
Google Scholar
PubMed
Close
,
Michelle Mangual Garcia Endocrinology

Search for other papers by Michelle Mangual Garcia in
Google Scholar
PubMed
Close
,
Paula Jeffs González Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Paula Jeffs González in
Google Scholar
PubMed
Close
,
Miosotis Garcia Endocrinology, Diabetes and Metabolism

Search for other papers by Miosotis Garcia in
Google Scholar
PubMed
Close
,
Guillermo Villarmarzo Endocrinology, Diabetes and Metabolism, San Juan City Hospital, Hato Rey Pathologies, San Juan, Puerto Rico

Search for other papers by Guillermo Villarmarzo in
Google Scholar
PubMed
Close
, and
Jose Hernán Martinez Endocrinology, Diabetes and Metabolism

Search for other papers by Jose Hernán Martinez in
Google Scholar
PubMed
Close

Summary

Classical papillary thyroid microcarcinoma (PTMC) is a variant of papillary thyroid carcinoma (PTC) known to have excellent prognosis. It has a mortality of 0.3%, even in the presence of distance metastasis. The latest American Thyroid Association guidelines state that although lobectomy is acceptable, active surveillance can be considered in the appropriate setting. We present the case of a 37-year-old female with a history of PTMC who underwent surgical management consisting of a total thyroidectomy. Although she has remained disease-free, her quality of life has been greatly affected by the sequelae of this procedure. This case serves as an excellent example of how first-line surgical treatment may result more harmful than the disease itself.

Learning points:

  • Papillary thyroid microcarcinoma (PTMC) has an excellent prognosis with a mortality of less than 1% even with the presence of distant metastases.

  • Active surveillance is a reasonable management approach for appropriately selected patients.

  • Patients should be thoroughly oriented about the risks and benefits of active surveillance vs immediate surgical treatment. This discussion should include the sequelae of surgery and potential impact on quality of life, especially in the younger population.

  • More studies are needed for stratification of PTMC behavior to determine if conservative management is adequate for all patients with this specific disease variant.

Open access